Background: Biofilm is a complex aggregate of microorganisms in which cells adhere to each other to a surface in a self-produced matrix of extra-cellular polymeric substance. Antibiotic resistance of bacteria in the biofilm mode of growth contributes to the chronicity of infections. Aims: This study was aimed to find out the prevalence of biofilm producers among the microorganisms isolated from our setup and to find out their antimicrobial susceptibility pattern with special reference to Extended Spectrum β-lactamase (ESBL) and AmpC producers. Settings and Design: It is a prospective, analytic study. Materials and Methods: The study included 169; non-repeat, clinical isolates of Enterobacteriaceae collected over a period of 6 months. All isolates were tested for biofilm production by tube adherence methods. Any bacterial species which showed resistance to any of third generation cephalosporin was tested for ESBL production and AmpC production. Statistical Analysis: Statistical analysis was carried out by taking percentage and simple ratios. Results: Among 169 isolates, 100 (59.2%) were biofilm producers. In our study, 44 (26%) and 43 (25%) isolates were ESBL and AmpC producers respectively. Of 44 ESBL producers, 42 (95.4%) and of 43 AmpC producers 39 (90.7%) were biofilm producers. Conclusions: Among 169 isolates, 26% and 25% were ESBL and AmpC producers. Of which, more than 90% were biofilm producers, which showed high resistance to commonly used antibiotics. Disabling biofilm resistance may enhance the ability of existing antibiotics to clear infections involving biofilms that are refractory to current treatments.